ZA200302911B - Method and composition for treatment of ocular hypertension and glaucoma. - Google Patents

Method and composition for treatment of ocular hypertension and glaucoma.

Info

Publication number
ZA200302911B
ZA200302911B ZA200302911A ZA200302911A ZA200302911B ZA 200302911 B ZA200302911 B ZA 200302911B ZA 200302911 A ZA200302911 A ZA 200302911A ZA 200302911 A ZA200302911 A ZA 200302911A ZA 200302911 B ZA200302911 B ZA 200302911B
Authority
ZA
South Africa
Prior art keywords
glaucoma
treatment
composition
ocular hypertension
ocular
Prior art date
Application number
ZA200302911A
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of ZA200302911B publication Critical patent/ZA200302911B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200302911A 2001-08-23 2003-04-14 Method and composition for treatment of ocular hypertension and glaucoma. ZA200302911B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31411001P 2001-08-23 2001-08-23

Publications (1)

Publication Number Publication Date
ZA200302911B true ZA200302911B (en) 2003-10-14

Family

ID=23218598

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200302911A ZA200302911B (en) 2001-08-23 2003-04-14 Method and composition for treatment of ocular hypertension and glaucoma.

Country Status (12)

Country Link
US (1) US20030060511A1 (enExample)
EP (1) EP1420793A1 (enExample)
JP (1) JP2004521960A (enExample)
KR (1) KR20040029012A (enExample)
CN (1) CN1575178A (enExample)
AR (1) AR036276A1 (enExample)
BR (1) BR0205932A (enExample)
CA (1) CA2458230A1 (enExample)
MX (1) MXPA04001604A (enExample)
NO (1) NO20031779D0 (enExample)
WO (1) WO2003018025A1 (enExample)
ZA (1) ZA200302911B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
WO2012137987A1 (en) * 2011-04-07 2012-10-11 Sucampo Ag Method for treating asthenopia

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932389A (en) * 1974-12-11 1976-01-13 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP0569046B1 (en) * 1988-09-06 2002-11-13 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) * 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE162074T1 (de) * 1988-10-01 1998-01-15 R Tech Ueno Ltd Oculare hypotensive mittel
US5194429A (en) * 1988-10-01 1993-03-16 K.K. Ueno Seiyaku Oyo Kenkyujo Ocular hypotensive agents
TW249226B (enExample) * 1990-04-04 1995-06-11 Aderk Ueno Kk
US5208256A (en) * 1990-05-22 1993-05-04 R-Tech Ueno, Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension

Also Published As

Publication number Publication date
CA2458230A1 (en) 2003-03-06
WO2003018025A1 (en) 2003-03-06
NO20031779L (no) 2003-04-22
MXPA04001604A (es) 2004-07-08
CN1575178A (zh) 2005-02-02
AR036276A1 (es) 2004-08-25
EP1420793A1 (en) 2004-05-26
JP2004521960A (ja) 2004-07-22
NO20031779D0 (no) 2003-04-22
US20030060511A1 (en) 2003-03-27
KR20040029012A (ko) 2004-04-03
BR0205932A (pt) 2004-02-17

Similar Documents

Publication Publication Date Title
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
AU2002305278A1 (en) Bifurcatable trabecular shunt for glaucoma treatment
AU2002236438A1 (en) Compositions and methods for treatment of mild cognitive impairment
EP1414464A4 (en) METHOD OF TREATING GLAUCOMA
IL158775A0 (en) Use of an antioxidant for treating and or preventing surface ocular disorders
EP1392292A4 (en) PYRANOINDAZOLES AND THEIR USE IN GLAUCOMA TREATMENT
IL160037A0 (en) Method and intra sclera implant for treatment of glaucoma and presbyopia
PL377172A1 (pl) Kompozycje do oczu do leczenia nadciśnienia śródgałkowego
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
ZA200309642B (en) Benzo (G) quinoline derivatives for treating glaucoma and myopia.
WO2004028451A8 (en) β-HYDROXYPHENYLALKYLAMINES AND THEIR USE FOR TREATING GLAUCOMA
ZA200302911B (en) Method and composition for treatment of ocular hypertension and glaucoma.
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom
AU2002246117A1 (en) Method for treatment and diagnosis of eye tissues
AU4114301A (en) Treatment of ocular hypertension and glaucoma
AU2003215820A8 (en) Method for treating ocular hypertension and glaucoma
AU2002322769A1 (en) Method for treatment of ocular hypertension and glaucoma
AU2001270642A1 (en) Method for the treatment of glaucoma and ocular hypertension by administering nucleotides
AU2003216547A8 (en) Compositions and methods for treating glaucoma and ocular hypertension
AU2001216038A1 (en) Treatment of glaucoma and ocular hypertension
AU2002330974A1 (en) Method and intra sclera implant for treatment of glaucoma and presbyopia
AU2002301864A1 (en) Drug-releasing trabecular implant for glaucoma treatment
EP1401351A4 (en) METHOD OF TREATING GLAUCOMA
WO2000062769A3 (en) Use of ap-1 activators to treat glaucoma and ocular hypertension